MedTrace Logo

Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model

NCT07721090 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2026-07-22

No results posted yet for this study

Summary

This study aims to improve how oral mucosal disorders-such as oral lichen planus, recurrent aphthous stomatitis, burning mouth syndrome, herpes viral infection and oral candidiasis-are treated in dental settings. A pharmacist will work with dentists to review prescriptions, provide feedback, counsel patients, and monitor medication safety. Dental clinics will be assigned to either the pharmacist-led model or usual care. The study will evaluate whether this approach improves prescribing quality, patient adherence, symptom control, and safety. The findings may help establish a more standardized, effective way to manage these common oral conditions in routine dental practice.

Conditions

  • Oral Lichen Planus
  • Recurrent Aphthous Stomatitis
  • Burning Mouth Syndrome
  • Oral Candidiasis
  • Herpes Virus Infection

Interventions

BEHAVIORAL

Pharmacist-Led Prescribing Optimization and Patient Counselling

This intervention involves a structured, pharmacist-led model integrated into routine dental care for patients with oral mucosal disorders. A clinical pharmacist will review dental prescriptions using standardized, evidence-based drug algorithms; provide audit and feedback to dentists; deliver structured patient counselling focused on correct medication use and adherence; and monitor for adverse drug reactions using validated tools. The intervention targets improvement in prescribing quality, medication safety, and patient outcomes, without introducing investigational drugs or altering standard treatment choices.

Sponsors & Collaborators

  • Sri Balaji Vidyapeeth University

    collaborator UNKNOWN

  • University of Fujairah

    lead OTHER

Principal Investigators

  • Tamer Hassan · Gulf Medical University

  • Ramam Sripada · Sri Balaji Vidyapeeth University

  • Nasma Pulikkalakath · Sri Balaji Vidyapeeth University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2027-11-30
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07721090 on ClinicalTrials.gov